Conditions associated with hypertrophy of the urinary bladder have repeatedly been associated with an increased urinary excretion of transforming growth factor (TGF)  in both rats and patients. Because TGF can have both growth-promoting and -inhibiting effects, we have studied its effects on cell growth and death in primary cultures of rat bladder smooth muscle cells. TGF1, TGF2, or TGF3 did not cause apoptosis, but all three isoforms inhibited DNA synthesis with similar potency (EC 50 of approximately 0.1 ng/ml) and efficacy. Such inhibition was antagonized by a specific TGF receptor antagonist and independent of the presence of serum. Mitogen-activated protein kinases (MAPKs) are involved in the control of cell growth, and all three TGF isoforms inhibited activation of the extracellular signal-regulated kinase, c-Jun NH 2 -terminal kinase, and p38 MAPK subfamilies. Nevertheless, the inhibitory effects of the TGF isoforms on DNA synthesis were not affected by presence of inhibitors of the three MAPK pathways. TGF did not alter cell size as measured by flow cytometry or mitochondrial activity, an integrated measure of cell size and number. We conclude that our data do not support the hypothesis that TGF is a mediator of rat bladder hypertrophy.Urinary bladder outlet obstruction (BOO) is a frequent consequence of benign prostatic enlargement or urethral strictures. It leads to an increased bladder size and micturition disorders (Andersson, 2003), the former involving both hypertrophy and hyperplasia at the cellular level. However, the mediators and molecular mechanisms leading to bladder hypertrophy have remained elusive. Studies in rats (Chul Kim et al., 2001) and patients with BOO (MacRae Dell et al., 2000;Monga et al., 2001) have found an increased urinary excretion of transforming growth factor (TGF) . Hence, TGF has been proposed to play a role in the pathophysiology of BOO and bladder hypertrophy.TGF is a pluripotent growth factor that has been implicated in a variety of physiological processes such as proliferation, apoptosis, phenotypic switching, differentiation, and specification of developmental fate (Massagué, 2000). Interestingly, TGF can have differential or even opposite effects depending on the tissue or cell type under investigation (Roberts and Sporn, 1993). For example, TGF can increase the proliferation of airway smooth muscle cells (Chen and Khalil, 2006), but it potently inhibits proliferation in vascular smooth muscle cells due to a G 0 /G 1 arrest via the p38 pathway (Seay et al., 2005). In the heart, TGF can induce cardiomyocyte hypertrophy, whereas cardiac fibroblasts respond with differentiation into myofibroblasts and synthesis of collagen Watkins et al., 2006). Therefore, it remains largely unclear whether increased TGF excretion in experimental and clinical BOO reflects a role as mediator of cell growth, as part of a negative feedback loop limiting cell growth, or as a by-product that at best can be used as a biomarker.The heterogeneity of TGF responses may...